Suppliers and packagers for generic pharmaceutical drug: MICONAZOLE

MICONAZOLE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Galt Pharms	ORAVIG	miconazole	TABLET;BUCCAL	022404	NDA	Galt Pharmaceuticals, LLC	61825-303-14	14 TABLET in 1 BOTTLE (61825-303-14)	2021-12-31

Supplier Landscape for Miconazole

Last updated: February 20, 2026

Which companies manufacture and supply miconazole globally?

Multiple pharmaceutical companies produce miconazole, a broad-spectrum antifungal used for topical, oral, and vaginal infections. The primary suppliers include:

• Bayer AG: One of the earliest patent holders, Bayer supplies topical formulations and active pharmaceutical ingredients (APIs) for prescription and over-the-counter products.

• Tianjin Zhongxin Pharmaceutical Group: Produces both APIs and finished formulations primarily for the Chinese market.

• Novartis AG: Historically involved in antibiotic and antifungal production, including miconazole formulations through partnerships.

• Zhejiang Huashi Pharmaceutical Co., Ltd.: Manufactures miconazole APIs for regional distribution within China and neighboring markets.

• Renowned generics manufacturers: Companies like Mylan, Sun Pharmaceutical Industries, and Dr. Reddy’s Laboratories produce miconazole topical creams, gels, and powders, often utilizing APIs from various suppliers.

API sourcing and regional producers

Most API production occurs in China and India:

Supplier	Location	API Production Scale	Certification
Tianjin Zhongxin Pharmaceutical	China	Large-scale, domestic	GMP certified
Zhejiang Huashi Pharmaceutical	China	Large-scale, regional	GMP, ISO certification
Orchid Chemicals & Pharmaceuticals	India	Significant capacity	GMP, ISO
Hetero Labs	India	Extensive API manufacturing	GMP, ISO
Dr. Reddy’s Laboratories	India	Global API supplier	GMP, ISO

Finished dosage form manufacturing

Companies producing finished miconazole products often source APIs from these suppliers and formulate into creams, gels, sprays, suppositories, and suspensions:

• Sun Pharmaceutical Industries (India)
• Taro Pharmaceuticals (USA)
• GSK (UK) – under now divested brands

Regulatory and quality considerations

APIs and finished products must meet GMP standards. Suppliers often obtain certifications from agencies such as the FDA, EMA, or NMPA (China’s National Medical Products Administration) to access different markets.

Supply chain dynamics

• API production predominantly in China and India creates a dependency risk linked to geopolitical tensions and trade policies.
• Certification and regulatory approval delays can impact market availability.
• Many finished product manufacturers rely on multiple API suppliers to mitigate supply disruptions.

Market trends affecting suppliers

• Increased demand during global health crises amplifies supply chain stresses.
• Stringent regulatory standards intensify the need for quality-certified suppliers.
• Regional regulatory shifts, such as China's drug approvals, influence API sourcing strategies.

Key conclusions

• API production for miconazole is concentrated mainly in China and India.
• Several large generic manufacturers produce finished products using APIs either sourced domestically or imported.
• Supply chain resilience depends on diversifying API sources and maintaining regulatory compliance.

Key Takeaways

• Major API suppliers are Tianjin Zhongxin (China), Zhejiang Huashi (China), Orchid (India), and Hetero (India).
• Finished product manufacturing relies heavily on regional players, with global distribution channels.
• Regulatory standards and geopolitical factors influence the supplier landscape and market stability.

FAQs

1. Are there alternative suppliers for miconazole APIs outside China and India?
Limited in scale; some manufacturers in Europe and North America produce APIs but at a smaller scale due to higher costs and regulatory hurdles.

2. How does geopolitical tension affect miconazole supply?
Trade restrictions or sanctions in China or India can disrupt API availability, leading to potential shortages.

3. What certifications are critical for miconazole API suppliers?
GMP certification by relevant authorities, ISO standards, and country-specific approvals like FDA or EMA approval.

4. Can finished drugs be sourced without domestic API production?
Yes, many finished products source APIs internationally, but reliance on imports can introduce supply and compliance risks.

5. Are there patent restrictions on miconazole?
In many jurisdictions, patents for miconazole have expired, enabling generic production without patent constraints.

References

1. U.S. Food and Drug Administration. (2022). API manufacturing and quality standards.
2. European Medicines Agency. (2023). Guidelines on API manufacturing.
3. Chinese State Food and Drug Administration. (2022). API certification and approval.
4. Indian Pharmaceutical Alliance. (2022). API manufacturing capacity and regulations.
5. MarketWatch. (2023). Global antifungal drug market overview.